Pier Capital, LLC Roivant Sciences Ltd. Transaction History
Pier Capital, LLC
- $670 Million
- Q3 2024
A detailed history of Pier Capital, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Pier Capital, LLC holds 429,908 shares of ROIV stock, worth $5.09 Million. This represents 0.74% of its overall portfolio holdings.
Number of Shares
429,908
Previous 425,087
1.13%
Holding current value
$5.09 Million
Previous $4.49 Million
10.42%
% of portfolio
0.74%
Previous 0.7%
Shares
7 transactions
Others Institutions Holding ROIV
# of Institutions
310Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$780 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$778 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$640 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$493 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$418 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.33B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...